|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Amortization of right-of-use assets | |||||
| Depreciation | |||||
| Change in fair value of short-term investment | |||||
| Non-cash warrant revenue | |||||
| Change in carrying value of long-term investment | |||||
| Non-cash underwriting revenues | |||||
| Non-cash commission expense | |||||
| Stock-based compensation – employees | |||||
| Stock-based compensation – advisors | |||||
| Realized gain on marketable securities | |||||
| Unrealized (gain) loss on marketable securities | |||||
| Unrealized (gain) loss on securities owned | |||||
| Realized and unrealized (gain) loss on note receivable | |||||
| Realized gain on receiving shares in exchange of note receivable extension | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other assets | |||||
| Prepaid acquisition cost | |||||
| Receivable from clearing brokers | |||||
| Accrued salaries and benefits | |||||
| Accounts payable and accrued expenses | |||||
| Accrued compensation and commissions | |||||
| Contract liabilities | |||||
| Right of use asset and liability, net | |||||
| Income taxes payable | |||||
| Securities owned | |||||
| Other liabilities | |||||
| Notes receivable, at fair value - net interest accrued | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of marketable securities | |||||
| Sale of marketable securities | |||||
| Purchase of fixed assets | |||||
| Acquisition of FPS, net of cash acquired and receivable owed from FPS | |||||
| Collection of principal on note receivable | |||||
| Funds to employee forgivable loan | |||||
| Purchase of short-term and long-term investments | |||||
| Loans to employees | |||||
| Purchase of long-term investments | |||||
| Redemption of long-term investments | |||||
| Collection of loans to employees | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Purchase of treasury stock | |||||
| Cash paid for Dividends | |||||
| Distributions to non-controlling interest | |||||
| Cash from issuance common stock, net of offering cost | |||||
| Cash from issuance common stock for exercised warrants | |||||
| Net cash provided by financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Cash paid for interest and taxes | |||||
| Supplemental cash flow disclosures including non-cash activities: | |||||
| Receiving shares in exchange of note receivable extension | |||||
| Note receivable principal and interest receivable reduced due to receiving shares | |||||
| Net assets acquired, net of cash acquired and receivable owed from FPS | |||||
| Less - Deposit previously transferred in October 2022 to FPS | |||||
| Transfer from long-term investment to marketable securities | |||||
| Right-to-use assets established | |||||
| Operating lease liabilities established | |||||
Loading...